News Theranos reaches tentative settlement with Walgreens Agreement could cost Theranos $30 million - significantly less than original $140 million lawsuit.
News Walgreens hits Theranos with $140m damages suit Walgreens claims to have been continually misled over Theranos' technology.
News Alzheimer's biotech Korsana to go public via reverse merger By merging with Cyclerion, Korsana will get a Nasdaq listing and additional cash to develop its new-generation amyloid-targeting drug for Alzheimer's.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
